WATSON 335 (Acyclovir 400 mg)

Pill imprint WATSON 335 has been identified as Acyclovir 400 mg.

Acyclovir is used in the treatment of herpes simplex, suppression; herpes simplex; ramsay hunt syndrome; herpes simplex encephalitis; herpes simplex, mucocutaneous/immunocompetent host (and more), and belongs to the drug class purine nucleosides. There is no proven risk in humans during pregnancy. Acyclovir 400 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for WATSON 335 (Acyclovir 400 mg)

Acyclovir 400 mg WATSON 335
Acyclovir 400 mg WATSON 335
400 mg
Elliptical / Oval
Prescription only
Drug Class:
Purine nucleosides
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Watson Pharmaceuticals
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-4765 A S Medication Solutions LLC (repackager)
54868-3997 Physicians Total Care Inc (repackager)
55887-0246 Diversified Healthcare Services Inc (repackager)
13411-0182 Advanced Pharmaceutical Services Inc (repackager)
63874-0500 Altura Pharmaceuticals Inc (repackager)
53002-0008 Pharmedix (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)